New study tracks pain relief after ablation for abdominal wall endometriosis
NCT ID NCT06268951
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 50 people undergoing a minimally invasive procedure called percutaneous ablation to treat endometriosis in the abdominal wall. Researchers will measure how well symptoms improve and how quickly patients recover using standard pain and quality-of-life surveys. The goal is to better understand the benefits and recovery timeline of this treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- percutaneous ablation
- What this could lead to
- If successful, this could confirm that ablation provides lasting symptom relief for abdominal wall endometriosis.
- What could go wrong
- This is a small, early observational study with no control group, so results may not prove the treatment is better than alternatives.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABDOMINAL WALL ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can yoga ease the pain of endometriosis after surgery?
- Building a biological treasure trove to decode Women's health mysteries
- Gaming for health: could a video game empower endometriosis patients?
- Can a new formulation of an endometriosis drug match the standard?
- Can a glowing dye reveal a Woman's fertility after ovarian cyst surgery?
- Can we predict endometriosis recurrence and fertility outcomes?